Bruno R. De Paula

Guildford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

New emerging data on adjuvant systemic therapy for stage I HER2 positive breast cancer.

New emerging data on adjuvant systemic therapy for stage I HER2 positive breast cancer.

Journal: Gland surgery

Published: February 02, 2025

Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer.

Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer.

Journal: Asian journal of surgery

Published: May 17, 2024

Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer.

Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer.

Journal: Annals of translational medicine

Published: October 02, 2023

Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer.

Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer.

Journal: International journal of molecular sciences

Published: October 12, 2022

Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer.

Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer.

Journal: Molecular cancer therapeutics

Published: September 29, 2022

Considerations of systemic treatment for matrix-producing carcinoma with curative intent.

Considerations of systemic treatment for matrix-producing carcinoma with curative intent.

Journal: Gland surgery

Published: August 25, 2022

Is it time to retire sentinel lymph node biopsy and use multi-omics prediction models?

Is it time to retire sentinel lymph node biopsy and use multi-omics prediction models?

Journal: Annals of translational medicine

Published: June 11, 2022

Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat.

Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat.

Journal: JCO precision oncology

Published: January 07, 2022

Personalising care in oesophageal cancer care with liquid biopsy.

Personalising care in oesophageal cancer care with liquid biopsy.

Journal: British journal of cancer

Published: February 16, 2021

Cannabinoids in glioblastoma multiforme-hype or hope?

Cannabinoids in glioblastoma multiforme-hype or hope?

Journal: British journal of cancer

Published: December 29, 2020

Rethinking cancer clinical trials for COVID-19 and beyond.

Rethinking cancer clinical trials for COVID-19 and beyond.

Journal: Nature cancer

Published: June 01, 2020

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.

Journal: The Lancet. Oncology

Published: March 31, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026